Comments
Loading...
ARS Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:SPRY | Benzinga
ARS Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 14
EPS
$-0.350
Quarterly Revenue
$7.97M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$97.12M
Analyze the earnings history of ARS Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals | -$0.13 | — | — | — | $500.00K | — | — | — | 08/05/2025 | Get Alert |
| SPRY | ARS Pharmaceuticals | -$0.11 | -$0.36 | -$0.35 | 2.78% | $0.00 | $7.48M | $7.97M | 6.59% | 05/14/2025 | Get Alert |
| SPRY | ARS Pharmaceuticals | -$0.07 | -$0.12 | $0.48 | 500.00% | $0.00 | $15.90M | $86.60M | 444.65% | 03/20/2025 | Get Alert |
| SPRY | ARS Pharmaceuticals | -$0.16 | -$0.15 | -$0.20 | -33.33% | $0.00 | $560.00K | $2.07M | 269.29% | 11/13/2024 | Get Alert |
| SPRY | ARS Pharmaceuticals | -$0.18 | -$0.12 | -$0.13 | -8.33% | $10.00K | $1.00M | $500.00K | -50.00% | 08/06/2024 | Get Alert |
| SPRY | ARS Pharmaceuticals | -$0.16 | -$0.11 | -$0.11 | 0.00% | $20.00K | — | $0.00 | — | 05/09/2024 | Get Alert |
| SPRY | ARS Pharmaceuticals | — | -$0.14 | -$0.07 | 50.00% | — | — | $0.00 | — | 03/21/2024 | Get Alert |
| SPRY | ARS Pharmaceuticals | -$0.21 | — | -$0.16 | — | — | — | $0.00 | — | 11/09/2023 | Get Alert |
| SPRY | ARS Pharmaceuticals | -$0.21 | -$0.17 | -$0.18 | -5.88% | $464.00K | — | $10.00K | — | 08/10/2023 | Get Alert |
| SPRY | ARS Pharmaceuticals | — | -$0.17 | -$0.16 | 5.88% | — | — | $20.00K | — | 05/15/2023 | Get Alert |
ARS Pharmaceuticals (SPRY) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-14 | $-0.35 | $-0.36 | 2.78 % |
| Q4 | 2025-03-20 | $0.48 | $-0.12 | 500.0 % |
| Q3 | 2024-11-13 | $-0.20 | $-0.15 | -33.3 % |
| Q2 | 2024-08-06 | $-0.13 | $-0.12 | -8.33 % |
ARS Pharmaceuticals (SPRY) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-14 | $7.97M | $7.48M | 6.59 % |
| Q4 | 2025-03-20 | $86.60M | $15.90M | 444.7 % |
| Q3 | 2024-11-13 | $2.07M | $560.00K | 269.3 % |
| Q2 | 2024-08-06 | $500.00K | $1.00M | -50.0 % |
FAQ
When is ARS Pharmaceuticals (NASDAQ:SPRY) reporting earnings?
ARS Pharmaceuticals (SPRY) is scheduled to report earnings on August 5, 2025. The last reported earnings were for reported on May 14, 2025 for Q1.
What were the latest earnings per share (EPS) for ARS Pharmaceuticals (NASDAQ:SPRY)?
The Actual EPS was $-0.35, which beat the estimate of $-0.36.
What were ARS Pharmaceuticals’s (NASDAQ:SPRY) revenues?
The Actual Revenue was $8M, which beat the estimate of $7.5M.
Browse earnings estimates, EPS, and revenue on all stocks.
